AiCuris Anti-infective Cures GmbH, a leading company in the discovery and development of drugs against infectious diseases gets involved in the fight against SARS-CoV-2 (Corona).
“In times like these, biotech and pharmaceutical companies have a great societal responsibility” said Dr. Holger Zimmermann, Chief Executive Officer of AiCuris. “We must ask ourselves how we can best help in such a situation. AiCuris has decided to provide unbureaucratic relief measures locally together with partners on short notice, and also evaluate suitable drug candidates in order to fight the current pandemic with united forces and at the same time prepare for future viral outbreaks.”
Short-term help for local and regional hospitals and health centers in the particularly heavily affected North Rhine-Westphalia
In parallel to the daily rapid increase in the number of individuals infected with SARS-CoV-2 the demand on the number of tests to detect the virus also increases. These tests are currently a very important measur in the fight against the virus. Fast diagnosis helps to quarantine infected patients quickly and thus prevent the spread of the virus to other people. Hospitals, medical practices and test stations are already reaching their capacities. The federal state of North Rhine-Westphalia, one of the most heavily affected states in Germany, is trying hard to increase its capacity for testing for SARS-CoV-2 infections. In cooperation with partners, AiCuris makes use of its expertise, network and laboratories to support clinics in the region and the NRW Health Minister in the field of diagnostics to help fill the capacity gap.